<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Evans,N.</style></author><author><style face="normal" font="default" size="100%">Pasman,H.R.</style></author><author><style face="normal" font="default" size="100%">T. Vega Alonso</style></author><author><style face="normal" font="default" size="100%">Van den Block,L.</style></author><author><style face="normal" font="default" size="100%">Miccinesi,G.</style></author><author><style face="normal" font="default" size="100%">Viviane Van Casteren</style></author><author><style face="normal" font="default" size="100%">G.A. Donker</style></author><author><style face="normal" font="default" size="100%">Bertolissi,S.</style></author><author><style face="normal" font="default" size="100%">Zurriaga,O.</style></author><author><style face="normal" font="default" size="100%">Deliens,L.</style></author><author><style face="normal" font="default" size="100%">B.D. Onwuteaka-Philipsen</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">End-of-life medical treatment preference discussions and surrogate decision-maker appointments: evidence from Italy, Spain, Belgium and the Netherlands</style></title><secondary-title><style face="normal" font="default" size="100%">B.M.J.Support.Palliat.Care</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">ALL</style></keyword><keyword><style  face="normal" font="default" size="100%">an</style></keyword><keyword><style  face="normal" font="default" size="100%">article</style></keyword><keyword><style  face="normal" font="default" size="100%">AS</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgian</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">Bt</style></keyword><keyword><style  face="normal" font="default" size="100%">care</style></keyword><keyword><style  face="normal" font="default" size="100%">Cognitive</style></keyword><keyword><style  face="normal" font="default" size="100%">CONTACT</style></keyword><keyword><style  face="normal" font="default" size="100%">Countries</style></keyword><keyword><style  face="normal" font="default" size="100%">cross sectional</style></keyword><keyword><style  face="normal" font="default" size="100%">Cross-sectional</style></keyword><keyword><style  face="normal" font="default" size="100%">Death</style></keyword><keyword><style  face="normal" font="default" size="100%">Decision</style></keyword><keyword><style  face="normal" font="default" size="100%">Decision Making</style></keyword><keyword><style  face="normal" font="default" size="100%">Decline</style></keyword><keyword><style  face="normal" font="default" size="100%">Dementia</style></keyword><keyword><style  face="normal" font="default" size="100%">Diagnosis</style></keyword><keyword><style  face="normal" font="default" size="100%">differences</style></keyword><keyword><style  face="normal" font="default" size="100%">Discussion</style></keyword><keyword><style  face="normal" font="default" size="100%">electronic</style></keyword><keyword><style  face="normal" font="default" size="100%">End-of-life</style></keyword><keyword><style  face="normal" font="default" size="100%">European</style></keyword><keyword><style  face="normal" font="default" size="100%">European countries</style></keyword><keyword><style  face="normal" font="default" size="100%">evidence</style></keyword><keyword><style  face="normal" font="default" size="100%">expertise</style></keyword><keyword><style  face="normal" font="default" size="100%">factors</style></keyword><keyword><style  face="normal" font="default" size="100%">GP</style></keyword><keyword><style  face="normal" font="default" size="100%">health</style></keyword><keyword><style  face="normal" font="default" size="100%">Institute</style></keyword><keyword><style  face="normal" font="default" size="100%">IS</style></keyword><keyword><style  face="normal" font="default" size="100%">ITALY</style></keyword><keyword><style  face="normal" font="default" size="100%">journal</style></keyword><keyword><style  face="normal" font="default" size="100%">Life</style></keyword><keyword><style  face="normal" font="default" size="100%">Logistic</style></keyword><keyword><style  face="normal" font="default" size="100%">logistic regression</style></keyword><keyword><style  face="normal" font="default" size="100%">Logistic-regression</style></keyword><keyword><style  face="normal" font="default" size="100%">medical</style></keyword><keyword><style  face="normal" font="default" size="100%">method</style></keyword><keyword><style  face="normal" font="default" size="100%">methods</style></keyword><keyword><style  face="normal" font="default" size="100%">Netherlands</style></keyword><keyword><style  face="normal" font="default" size="100%">Network</style></keyword><keyword><style  face="normal" font="default" size="100%">networks</style></keyword><keyword><style  face="normal" font="default" size="100%">OCCUPATIONAL</style></keyword><keyword><style  face="normal" font="default" size="100%">Occupational Health</style></keyword><keyword><style  face="normal" font="default" size="100%">Palliative Care</style></keyword><keyword><style  face="normal" font="default" size="100%">Participation</style></keyword><keyword><style  face="normal" font="default" size="100%">Patient</style></keyword><keyword><style  face="normal" font="default" size="100%">Patient Participation</style></keyword><keyword><style  face="normal" font="default" size="100%">patients</style></keyword><keyword><style  face="normal" font="default" size="100%">Planning</style></keyword><keyword><style  face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style  face="normal" font="default" size="100%">public</style></keyword><keyword><style  face="normal" font="default" size="100%">regression</style></keyword><keyword><style  face="normal" font="default" size="100%">Research</style></keyword><keyword><style  face="normal" font="default" size="100%">result</style></keyword><keyword><style  face="normal" font="default" size="100%">results</style></keyword><keyword><style  face="normal" font="default" size="100%">Spain</style></keyword><keyword><style  face="normal" font="default" size="100%">study</style></keyword><keyword><style  face="normal" font="default" size="100%">surrogate</style></keyword><keyword><style  face="normal" font="default" size="100%">survey</style></keyword><keyword><style  face="normal" font="default" size="100%">The Netherlands</style></keyword><keyword><style  face="normal" font="default" size="100%">treatment</style></keyword><keyword><style  face="normal" font="default" size="100%">Universities</style></keyword><keyword><style  face="normal" font="default" size="100%">university</style></keyword><keyword><style  face="normal" font="default" size="100%">WHO</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1/6/2013</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">3</style></volume><pages><style face="normal" font="default" size="100%">235</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">BACKGROUND: Making treatment decisions in anticipation of possible future incapacity is an important part of patient participation in end-of-life decision-making. AIM: To compare the prevalence of GP-patient end-of-life treatment discussions and patient surrogate appointments in Italy, Spain, Belgium and the Netherlands and examine associated factors. METHODS: A cross-sectional, retrospective survey was conducted with representative GP networks in four countries. GPs recorded the health and care characteristics in the last 3 months of life of patients who died non-suddenly. Prevalences were estimated and between country differences, and country-specific associated patient and care factors, were examined using logistic regressions. RESULTS: 4396 non-sudden deaths were included. GP-patient discussion of treatment preferences occurred for 10%, 7%, 25% and 47% of Italian, Spanish, Belgian and of Dutch patients respectively. Furthermore, 6%, 5%, 16% and 29% of Italian, Spanish, Belgian and Dutch patients had a surrogate decision-maker. Despite some country-specific differences, previous GP-patient diagnosis discussions, more frequent GP contact, GP provision of palliative care, the importance of palliative care as a treatment aim and place of death were positively associated with preference discussions or surrogate appointments. A diagnosis of dementia was negatively associated with preference discussions and surrogate appointments. The single most important factor was prior GP-patient diagnosis discussion. DISCUSSION: The study revealed a higher prevalence of treatment preference discussions and surrogate appointments in the two northern European countries. CONCLUSION: Delaying diagnosis discussions impedes anticipatory planning, whereas early discussions for all patients, particularly those with cognitive decline, and palliative care provision support patients' participation in decision-making</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><custom1><style face="normal" font="default" size="100%">456</style></custom1><section><style face="normal" font="default" size="100%">235</style></section></record></records></xml>